Jason Kneeland
Comptroller/Controller/Auditor at ACER THERAPEUTICS INC.
Profile
Jason Kneeland is currently the Vice President-Finance & Controller at Acer Therapeutics, Inc. He previously worked as the Vice President-Finance at TechTarget, Inc. and as a Senior Manager at Corporate Finance Group, Inc. He obtained an undergraduate degree from Johnson & Wales University, Inc.
Jason Kneeland active positions
| Companies | Position | Start |
|---|---|---|
| ACER THERAPEUTICS INC. | Comptroller/Controller/Auditor | - |
Former positions of Jason Kneeland
| Companies | Position | End |
|---|---|---|
| TECHTARGET, INC. | Corporate Officer/Principal | 01/11/2017 |
Corporate Finance Group, Inc.
 Corporate Finance Group, Inc. Miscellaneous Commercial ServicesCommercial Services Corporate Finance Group, Inc. provides financial consulting services. It offers private equity services, CFO services, consulting, interim management, corporate tax, and valuation. The company was founded by Arnold Tinter, Nicholas Nardone and Shane Caiazzo in 2000 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/08/2013 |
Training of Jason Kneeland
| Johnson & Wales University, Inc. | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TECHTARGET, INC. | Technology Services |
| Private companies | 2 |
|---|---|
Corporate Finance Group, Inc.
Corporate Finance Group, Inc. Miscellaneous Commercial ServicesCommercial Services Corporate Finance Group, Inc. provides financial consulting services. It offers private equity services, CFO services, consulting, interim management, corporate tax, and valuation. The company was founded by Arnold Tinter, Nicholas Nardone and Shane Caiazzo in 2000 and is headquartered in Boston, MA. | Commercial Services |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Stock Market
- Insiders
- Jason Kneeland
